Professional
Added to YB: 2024-02-19
Pitch date: 2024-01-18
LQDA [bullish]
Liquidia Corporation
+182.45%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
Market Cap
$3.0B
Pitch Price
$13.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
-61.70
P/E
-42.93
EV/Sales
18.94
Sector
Pharmaceuticals
Category
special_situation
Show full summary:
Arquitos Capital Management Portfolio Holding - Liquidia
LQDA +68% in Dec on PAH patent win vs UTHR. CEO Jeffs (ex-UTHR) bought $1M pre-ruling, owns $30M+. Yutrepia launch in Apr, touting better delivery for higher/safer doses. Jeffs sees 20-90% share gain. 1% UTHR royalty valued at $150M, 50% share = 7x+ upside potential.
Read full article (2 min)